• Title Slide 2

    Vibrant biomedical research campus situated in the beautiful Sonoran Desert Ecosystem.

  • Student Slide

    Multidisciplinary program to train the next generation of biomedical scientists.

  • Title

    Probing the mysteries of human health and disease.

  • Title Slide 3

    Collaborative research environment harnessing leading-edge technology and training.

A multidisciplinary PhD program focused on outstanding scholarship in the fields of immunobiology, molecular biophysics, and cell biology

Home Page

Over 50 Faculty and 30 PhD Students

The Cellular and Molecular Medicine (CMM) and Immunobiology (IMB) graduate programs at the University of Arizona have merged to create the Graduate Program in Molecular Medicine (GPMM). GPMM is an interdepartmental, multidisciplinary training program that fosters the development of scientists and educators who are prepared for lifelong participation in research and other intellectual pursuits. With an emphasis on bridging basic and translational science, Molecular Medicine trainees receive advanced training in the theory and practice of biomedical science. There are opportunities to investigate human health and disease ranging from biophysical studies at the atomic level, to modeling critical cellular process in tractable systems, to clinical research. The exposure and skills that our trainees acquire prepare them for careers in biomedical research (including academia and the biotechnology industry), science education, journalism, and public policy.

Cell Biology

Cell Biology

To provide students with a foundation for understanding the cellular underpinnings of human health and disease, while advancing the field through hands-on, cutting-edge research.

Medical Biophysics

Medical Biophysics

Apply quantitative multi-disciplinary approaches to molecular and integrative biology with a goal to understand the biophysical basis of health and disease mechanisms, identify drugable targets and contribute to Precision Medicine.

Immunobiology

Immunobiology

Advance the insights into the rules of engagement that determine the outcome of host-pathogen interactions to develop future therapies for infectious, autoimmune and malignant diseases.

News

Dr. Felicia Goodrum named the 2022 Edith Sayre Auslander Emerging Visionary


Dr. Julie Ledford and Co-PIs Awarded $3.4M Grant for RaeSedo Inc. to Develop New Therapies for Asthma

Dr. Julie Ledford and her co-principle investigators were awarded a Phase 2 Small Business Technology Transfer grant for their startup company RaeSedo, Inc. The project is titled, "Development of SP-A Derived Peptidomimetics for the Treatment of Asthma" and the total award will amount to $3.4 Million over two years. Dr. Scott Boitano (UArizona), Dr. Josef Vagner (UArizona), and Dr. Monica Kraft (Mount Sinai Medicine) are the co-principle investigators on the project. Click for more about their company, RaeSedo.
Dr. Paul Gignac Awarded $1 Million NSF Grant to Form Research Coordination Network

Associate professor Paul Gignac in the department of Cellular and Molecular Medicine has been awarded $1 million by the National Science Foundation to form a Research Coordination Network focused on improving computed tomography data access and stewardship.
Dr. Maria Czuzak Honored with COM-T Mentoring Award

Maria Czuzak, PhD, Associate Professor of Cellular & Molecular Medicine and Director of Anatomy, received a 2022 Faculty Mentoring Award from the College of Medicine - Tucson. These awards recognize the importance of mentorship for the success of the medical college faculty.